Bixiye
bc-com-pharmprogpolicynotifctn-final-4.10.23-eff-6.1.23.pdf
Natiijooyinka Raadinta
Soo bandhiga 1171 - 1180 ee natiijooyinka 4229
Bixiye
QP27-23 Commercial and MHCP Pharmacy Benefit Exclusion for Syfovre™
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 12, 2023
Bixiye
QP28-23 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2023
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 12, 2023
Bixiye
QP29-23 Blue Cross Preferred Genetic Laboratory Program
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 12, 2023
Faa'iidooyinka & Caymiska
Minnesota Senior Care Plus 2023 Member Handbook
Faa'iidooyinka & Caymiska
MinnesotaCare 2023 Member Handbook
Bixiye
QP110-22 Medication Therapy Management Program
Taariikhda uu dhaqangalayo Barnaamijka: Des 28, 2022
Bixiye
QP111-22 Commercial Pharmacy Benefit Exclusion for Tzield™
Taariikhda uu dhaqangalayo Barnaamijka: Des 28, 2022
Bixiye
QP112-22 MHCP Pharmacy Benefit Exclusion for Elahere™ and Tzield™
Taariikhda uu dhaqangalayo Barnaamijka: Des 28, 2022